Drug intelligence / Profile preview

melatonin + zinc

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

**Melatonin + zinc** is a combination dietary supplement composed of melatonin, a neurohormone primarily involved in the regulation of circadian rhythms and sleep, and zinc, an essential trace element with antioxidant, immunomodulatory, and enzymatic functions. This combination has primarily been investigated as an adjuvant or supportive therapy in various chronic conditions and experimental models. Independent clinical and preclinical studies indicate potential synergistic effects on reducing fatigue and improving physical quality of life in myalgic encephalomyelitis/chronic fatigue syndrome, and on neuroprotection and attenuation of neurotoxicity via antioxidant and anti-inflammatory mechanisms. Preclinical studies show the combination may boost the antioxidant system (increasing glutathione peroxidase, superoxide dismutase), reduce neuroinflammatory markers (such as TNF-α and GFAP), and modulate expression of apoptosis-related proteins (such as p53), thereby protecting against neurodegenerative and neuropathic conditions[1][2][3]. Clinical trial evidence suggests safety and benefit in improving fatigue and sleep quality, but it is primarily used as a dietary supplement and not as an approved pharmaceutical drug[3].

Other names
melatonin plus zincmelatonin and zinc
02

Targets

TP53 (Cellular Tumor Antigen p53 R175H)TNFA (Tumor necrosis factor alpha (soluble))GFAP (Glial fibrillary acidic protein)MTNR1A (MT1)MTNR1B (Melatonin Receptor 2)

Beyond the preview

Go deeper on melatonin + zinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on melatonin + zinc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call